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Abstract
Background: Microarray data interpretation can be affected by sample RNA integrity. The ScreenTape Degradation
Value (SDV) is a novel RNA integrity metric specific to the ScreenTape® platform (Lab901). To characterise the
performance of the ScreenTape® platform for RNA analysis and determine the robustness of the SDV metric, a
panel of intentionally degraded RNA samples was prepared. These samples were used to evaluate the ScreenTape®
platform against an alternative approach for measuring RNA integrity (Agilent Bioanalyzer RIN value). The samples
were also subjected to microarray analysis and the resulting data correlated to the RNA integrity metrics.
Findings: Measurement of SDV for a panel of intentionally degraded RNA samples ranged from 0 for intact RNA to
37 for degraded RNA, with corresponding RIN values ranging from 10 to 4 for the same set of samples. SDV and RIN
scales both demonstrated comparable discrimination between differently treated samples (RIN 10 to 7, SDV 0 to 15),
with the SDV exhibiting better discrimination at higher degradation levels. Increasing SDV values correlated with a
decrease in microarray sample labelling efficiency and an increase in numbers of differentially expressed genes.
Conclusions: The ScreenTape® platform is comparable to the Bioanalyzer platform in terms of reproducibility and
discrimination between different levels of RNA degradation. The robust nature of the SDV metric qualifies it as an
alternative metric for RNA sample quality control, and a useful predictor of downstream microarray performance.
Background
The use of microarray technology has revolutionised the
fields of molecular biology and genetics. However, con-
cerns have been raised over the numerous potential
sources of variation that can affect assay consistency
and data quality [1,2]. Previous studies have highlighted
RNA integrity as one source that has a major effect on
microarray data quality [3-5].
T od a t e ,n os i n g l eR N Ai n t e g r i t ym e t r i ch a sb e e n
adopted universally by the research community. RNA
quality is commonly determined by several different
techniques, including the ribosomal peak ratio (eukaryo-
tic 28s/18s rRNA peak intensity ratio) [6], RIN [7], 5’/3’
transcript signal intensity ratio determined by qRT-PCR
or microarray analysis [8] and other quality indices [9].
RNA purity is assessed routinely by measuring the
OD260 nm/OD280 nm ratio [6,10,11] of a sample.
However, this metric yields no information about RNA
integrity. Molecular biologists have therefore relied on
the technique of gel electrophoresis, which provides a
reproducible separation of ribosomal RNA (rRNA)
molecules to derive overall sample RNA integrity. Cur-
rently, such conventional methods are being replaced by
microfluidic-based platforms, such as that developed by
Agilent Technologies (2100 Bioanalyzer).
More recently, Lab901 have developed a novel electro-
phoretic ScreenTape
® platform that employs precast
multilane gels and microfluidics enabling semi-auto-
mated operation, simplifying sample handling and redu-
cing assay times. In this study we have compared the
performance characteristics of the ScreenTape
® R6K
platform (Lab901) and corresponding RNA quality
metric, SDV [9] with the 2100 Bioanalyzer and asso-
ciated quality metric, RIN [7].
We report here on the broad correlation observed for
these quality metric values and associated microarray data.
Methods
RNA preparation
HepG2 cells (passage = 84) were grown to confluence in
T175 vented culture flasks, using Eagles Minimum
Essential Medium (EMEM, ATCC) plus 10% Foetal Calf * Correspondence: TIMOTHY.WILKES@LGC.CO.UK
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plemented with 5% CO2. Cells were then exposed for
24 h to EMEM exposure media supplemented with 0.5%
(v/v) DMSO vehicle (Sigma Aldrich) and 4 mM ACAP
(Paracetamol, Sigma Aldrich). Following treatment, the
cells were washed with an excess of 1 × Phosphate Buf-
fered Saline (Gibco) before being lysed in situ by the
application of ice cold TRIzol
® LS Reagent (Invitrogen).
Total RNA was then isolated according to manufac-
turer’s instructions (Invitrogen). RNA quantity was
determined using a NanoDrop 1000 spectrophotometer.
Instrumentation
For comparative analysis of RNA integrity, the Tape
Station
® (Lab901) was used in conjunction with Screen-
Tape
® R6K, and the 2100 Bioanalyzer (Agilent Technol-
ogies) with the RNA 6000 series II Nano LabChip
analysis kit. Total RNA samples were prepared for ana-
lysis according to manufacturer’s recommendations.
Results were compared between the platforms for six
levels of RNA sample integrity and at a single RNA con-
centration of 25 ng/μl.
RNA degradation
RNA from the treated HepG2 cells was diluted to a con-
centration of 1 μg/μl with nuclease-free water (Ambion)
a n da l i q u o t e di n t ov o l u m e so f5 0μl in 0.2 ml thin wall
PCR tubes. The tubes were placed in the block of an MJ
Research PTC-200 DNA Engine Thermal Cycler PCR
machine which was then heated to 90°C. Tubes were
removed in batches of three at 3-minute intervals. The
RNA was then diluted to 25 ng/μl with nuclease-free
water, and RNA integrity for each sample determined
on both platforms.
Microarray experimental design
A single-colour labelling approach was adopted for the
microarray hybridisation scheme. Duplicate biological
samples of those employed for the Lab901/Bioanalyser
platform evaluation were used, with two technical repli-
cates (arrays) for each sample. Samples were hybridized
to Agilent Homo sapiens 4 × 44K whole genome gene
expression arrays according to manufacturer’si n s t r u c -
tions. The hybridised arrays were scanned using an Agi-
lent G2505B Scanner and expression data extracted using
Feature Extraction software, version 10.5 (Agilent Tech-
nologies). Data was exported to the Genespring GX (Agi-
lent) software package, normalised to the 75th percentile
of the data set and base-lined to the median signal inten-
sity of all chips. The data were quality controlled by fil-
tering on flags (features present and marginal), before the
number of differentially expressed genes (DEG) were
determined using the combination of an analysis of var-
iance (ANOVA) and relative fold change (FC = > 1.5).
Statistical treatment
All statistical analysis used R version 2.9.2 [12].
Results and discussion
RNA Integrity Measurements
RNA integrity was assessed for RNA samples with
increasing levels of degradation using the Lab901
ScreenTape
® system, which generates SDV values,
and the Agilent Bioanalyzer, which generates RIN
values. Replicate samples were run on three separate
chips or tapes, depending on the platform, and across
triplicate lanes per chip or tape. An overlay of chro-
matograms generated by the ScreenTape
® and Bioa-
nalyzer systems for intact and degraded RNA is
presented in Figure 1.
Comparison with RNA Integrity Number (RIN)
RIN is an incremental scale which spans from 0 to 10,
with increasing RNA integrity correlating with increas-
ing RIN value. In contrast, SDV is an unconstrained
metric which employs a scale of measurement spanning
from 0 to infinity with higher values corresponding to
increased degradation. A direct comparison of SDV to
RIN was carried out to evaluate the performance of the
SDV metric. Preliminary inspection of the data for
both platforms (Figure 2) illustrates several important
features:
(i) Both RIN and SDV show good discrimination
between samples in general.
(ii) SDV appears to show generally better within-
group precision.
(iii) There is evidence to suggest that RIN and SDV
do not share a linear relationship.
(iv) The within-group dispersion does not appear to
be constant across treatment groups for either of the
metrics.
Performance comparison
The assessment of relative platform performance was
determined by the use of three different statistical indi-
cators, namely rank order correlation, intraclass correla-
tion and classification performance
i) Rank order correlation
Spearman (r) and Kendall (τ) rank correlations between
response and RNA integrity level are listed in Table 1.
Both correlation measures indicate very good perfor-
mance, with the SDV performance appearing marginally
better. However, based upon bootstrapping studies
(5000 resamples with 95% BCa confidence interval [13]
calculated for the difference in magnitude), the differ-
ence in rank correlation is not significant at the 95%
level of confidence.
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Table 2 lists the calculated intraclass correlation coeffi-
cients (ICC) for each metric with respective calculated
confidence intervals.
The ICC for both metrics are high, which is indicative
of good performance. The observed ICC for SDV is
marginally higher but the confidence intervals show that
the difference is not significant at the 95% level of
confidence.
iii) Classification performance
Four supervised classification methods (rank ordering,
Gaussian, K-nearest neighbour (KNN) and linear discri-
mination analysis (LDA)) were applied to the data sets
and the resulting groupings compared with the expected
g r o u p i n g s .T h es i g n i f i c a n c ef o rd i f f e r e n c e si nt h ep r o -
portion of misclassifications between the RIN and SDV
metrics were then tested for each of the classification
methods employed. Table 3 summarises these results in
terms of the number of misclassifications observed and
associated p-values.
It can be seen that the relative performance of the two
RNA degradation metrics is consistent across all four
classification methods. However, more misclassifications
were observed when using the RIN metric. In addition,
the difference in misclassification was found to be
significant at the 95% level for two of the four classifica-
tion methods. This would indicate that a significant dif-
ference in performance exists between the SDV and
RIN metrics.
Microarray analyses
RNA integrity and labelling efficiency
Gene expression studies are potentially sensitive to the
effect of RNA integrity. To determine the broad impact
of RNA integrity on microarray data, and to determine
the value of the SDV metric in highlighting potential
problems, microarray labelling data was generated for
the degraded RNA samples used in this study. The pro-
cedure recommended by Agilent for the amplification
and labelling of mRNA samples employs a 3’ mediated
Eberwine amplification protocol [14] that introduces a
directional bias into the pool of synthesised cRNA. Pro-
gressive degradation of the RNA template will reduce
the population fragment size and is expected to lead to
a reduced labelling efficiency. Plotting of the labelling
data demonstrates that reduced RNA integrity leads to
reduced sample labelling (Cyanine 3 (pmol/μgR N A ) )
(Figure 3).
In terms of microarray assay performance, reduced
sample labelling efficiency may have an impact on the
Figure 1 SDV and RIN chromatograms. Graphical overlay of SDV chromatograms for the analysis of intact (A), and degraded (B) RNA. RIN
chromatograms for intact (C) and degraded (D) RNA are shown for comparison.
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ity. RNA integrity measurement, whether by SDV or
RIN, may provide a valuable tool for early prediction of
RNA labelling efficiency and ultimately of overall micro-
array performance.
Microarray data
Assay sensitivity (the rate of detection of true positives)
and specificity (the rate of detection of true negatives)
are important performance indicators for microarray
experiments. To gain insight into the broad impact of
RNA integrity, as determined by SDV, a preliminary
gene expression experiment was performed using the
samples from this study. For each data set generated
using different levels of RNA integrity, the number of
differentially expressed genes (DEGs) was determined by
Figure 2 Relationship between SDV and RIN. Comparison of the SDV and RIN integrity metrics for a panel of seven RNA samples. “Treatment”
denotes the duration of thermal degradation treatment used. Each group includes nine observations, except for treatment four which
corresponds to a 12-minute incubation at 90°C and, which includes only seven observations. The thicker horizontal line shows the median,
boxes show the upper and lower quartiles and whiskers extend to the most distant data point within 1.5 times the interquartile range of the
relevant quartile. Values beyond this are shown as individual data points.
Table 1 Rank correlations (observed vs. treatment level)
Spearman r Kendall τ
RIN 0.984 0.927
SDV -0.990 -0.934
Spearman (r) and Kendall (τ) rank correlations between observed RNA
integrity level and degradation treatment time.
Table 2 Intraclass correlation coefficients
ICC* 95% Confidence interval**
RIN 0.981 (0.949, 0.997)
SDV 0.992 (0.979, 0.998)
* Intraclass correlation coefficient ICC(1) from reference [15]
** Calculated as in reference [15]
Calculated intraclass correlation coefficients with associated calculated
confidence intervals.
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intact RNA extracted from HepG2 cells treated with
vehicle control only (DMSO). To assign a measure of
assay specificity to the data, a value for the degree of
additional gene discovery (“Additional Discovery Rate”,
ADR) at each level of RNA integrity was derived by sub-
tracting the median number of Differentially Expressed
Genes (DEGs) for the technical replicates of the intact
sample from the median number of DEGs determined
for each of the degraded samples (Table 4).
Differential expression was defined as those genes
which demonstrated a statistically significant difference
of expression (p ≤ 0.05) while employing a Benjamini
and Hochberg [15] false discovery rate correction factor,
and a fold change ≥ 1.5 compared to the control. The
additional gene discovery rate was determined by sub-
tracting the median number of genes determined for
three technical replicates of an intact RNA sample away
from the median number of genes derived from three
technical replicates at each level of degraded RNA
sample.
It has been reported previously that gene expression
profiling using Affymetrix GeneChip arrays is relatively
tolerant to moderate RNA degradation as well as to 5’
truncation occurring as a consequence of successive
rounds of in vitro transcription [16]. However, with pro-
gressively decreasing RNA integrity, a substantial
increase in the rate of detection of additional positives is
reported here, particularly with RIN values < 7 [3].
Comparing RIN or SDV with the ADR reveals a pro-
gressive increase in the ADR with decreasing RNA
integrity. The exact nature of this increase is uncertain
at this stage, but these findings indicate that a shift in
Table 3 Misclassification rates
Classification method RIN SDV p-value
Sample ranking 8/61 0/63 0.009
Gaussian classifier 7/61 1/63 0.061
KNN 7/61 0/63 0.017
LDA 8/61 2/63 0.089
Table shows the number of misclassified observations and the total number
of observations (two observations were missing from the 9-minute treatment
set). All the observed misclassifications were found to be assigned to adjacent
treatment groups. Note that for KNN, the misclassification rate varies from run
to run due to random tie-breaking (values from 6 to 8 were observed for the
9-minute treatment); the value of 7 given here for KNN was the modal value
for 100 KNN reruns.
Figure 3 Relationship of labelling efficiency to sample RNA integrity. The impact of RNA integrity on microarray sample labelling as
evaluated by measurement of Target Specific Activity (Cyanine 3 (pmol/μg RNA)) for an identical mass of input RNA at each level of integrity.
Wilkes et al. BMC Research Notes 2010, 3:89
http://www.biomedcentral.com/1756-0500/3/89
Page 5 of 7assay specificity is occurring as a consequence of
reduced RNA integrity, which can be accurately mea-
sured and predicted with SDV and RIN.
Conclusions
The measurement of gene expression is based on the
assumption that an analysed RNA sample accurately
represents the population of transcripts present in vivo
[17]. Many transcripts demonstrate stability differences
of several orders of magnitude in vivo [18], raising the
possibility that partial sample degradation could cause
variable bias in transcript quantification. The adoption
of a suitable RNA quality metric with the capacity to
accurately determine RNA integrity is therefore an
essential prerequisite for robust data generation in any
expression profiling experiment.
In this paper we have compared both the performance
of the novel Lab901 ScreenTape
® platform with that of
the Agilent 2100 Bioanalyzer and also compared the
S D Vm e t r i cw i t ht h eR I Nm e t r i cf o rt h ed e t e r m i n a t i o n
of RNA integrity when applied to microarray data
analysis.
Both metrics performed well when using the samples
employed in this study, with the data highlighting the
difficulty associated with unambiguously assigning sam-
ples to a definitive integrity level when they have ether a
RIN value ≤ 6 or an SDV value ≥ 15.
In conclusion, the ScreenTape
® system was demon-
strated to be a reliable and robust means of determin-
ing RNA integrity with SDV estimates, correlating well
with the RIN values generated by the Agilent Bioanaly-
zer platform and with a better classification perfor-
mance in this study. In addition, the RIN and SDV
metrics both performed well in terms of distinguishing
different levels of RNA degradation treatment. For
microarray data, Rank correlations with treatment and
intraclass correlations are high. Classification methods
show that the majority of observations were classified
into appropriate treatment groups by both RIN and
SDV, with the slightly better classification performance
of the SDV metric being significant at the P ≤ 0.05
level for two out of the four classification methods
used.
The ScreenTape platform and SDV therefore offer an
alternative to currently available systems for RNA integ-
rity analysis and provide a performance comparable to
that of the Bioanalyzer 2100. The rapid assay time and
medium through put capacity may favour its use in
laboratories which process large numbers of samples.
Future studies with this platform could enable the devel-
opment of an SDV based RNA quality threshold to be
established for use with downstream applications.
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